Applications Published 27 December 2000

Delivery system to modulate immune response
Allergenics 1061903*

Nanoparticles, method for producing nanoparticles, and use of the same
Aventis Research & Technologies 1061904*

Methods and compsns for detection and daignosis of infectious diseases Japan BCG Laboratory;
Nakamura, Reiko 1061905*

Monolithic tablet for controlled release
Temple University of the Commonwealth System of Higher Education 1061906*

Monoterpenoid derivatives for the treatment of cancer
Wisconsin Alumni Research Foundation 1061907*

Combination therapy and compsn for acute coronary ischemic syndrome and related conditions
Merck 1061908*

Keto acid salts and amine derivatives and their use for preparing medicines
Chiesi 1061909*

Use of alpha-RAR antagonists for inhibition of mucin secretion
F Hoffmann-La Roche 1061910*

Novel methods for treating disroders in which docosahexanoic acid (DHA) levels are affected.

Beth Israel Deaconess Medical Centre 1061911*

Phenanthrofuran derivatives
Phytera 1061912*

The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
The Johns Hopkins University School of Medicine 1061913*

Lipoic acid analogues
Regents of the University of California 1061914*

Pharmaceutical formulations of taxanes
Bionumerik Pharmaceuticals 1061915*

Use of nitrone compounds for the treatment of angiogenesis
Centaur Pharmaceuticals 1061916*

Methods of inhibiting bone resorption
Merck 1061917*

Novel opiate compounds, methods of making and methods of use
Carrol, Frank; Mascarella, Wayne; Thomas, James 1061919*

Pharmaceutical formulation comprising a 2[[(2-pyridinyl)methyl]sulphinyl]benzimidazole having anti-ulcer activity and a process for the preparation of such formulation
A/S GEA Farmaceutisk Fabrik 1061920*

Vitronectin receptor antagonists
SmithKline Beecham 1061921*

Metal chelators for use in the treatment of Alzheimer's disease
The General Hospital Corp 1061922*

Treatment of compulsive behaviours in man and animals
Trustees of Tufts College 1061924*

Combination of a GABA-A alpha 5 inverse agonist and a nicotinic agonist
Merck Sharp & Dohme 1061925*

Heterocyclic compounds, their production and use as tachykinin receptor antagonists
Takeda Chemical 1061926*

Compsn for reducing serum cholesterol levels
Sorkin, Harlan 1061927*

New contraceptive kit
Akzo Nobel 1061928*

Pharmaceutical compsn based in natural synthesis progestrone and oestradiol and preparation method Laboratoires BESINS
ISCOVESCO 1061929*

Thrombin preparation and products and fibrin sealent methods employing same
Baxter 1061931*

Pharmaceutical compsn containing extracts of Cervus nippon antlers having growth-stimulating activities of hematopoietic stem cells and megakaryocytes
Jhon, Gil Ja; Yang, Hyun Ok; Kim, Yang Mi; Kim, Sang Hee; Shu, Gi Young; Han, So Yeop 1061932*

Fibronectin peptides-based extracellular matrix for wound healing
The Research Foundation of State University of New York 1061933*

Proapoptotic peptides, dependence polypeptides and methods of use
The Burnham Institute 1061935*

Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
Georgetown University 1061936*

Improved radiation therapy methods
University of South Carolina 1061937*

Oral compsns at low dosages of cytotoxic proteins
Zetesis 1061938*

Recombinant fibronectin-based extracellular matrix for wound healing
The Research Foundation of the State University of New York 1061939*

Use of follistatin to modulate GDF-8 and BMP-11
Genetics Institute 1061940*

A pharmaceutical compsn containing ezrin mutated on tyrosine 353
Institut Curie; Centre National de la Recherche Scientifique 1061941*

Topical compsn containing human epidermal growth factor
Daewong Pharmaceutical 1061942*

Method of preventing the death of retinal neurons and treating ocular diseases
Genentech 1061943*

Therapeutic chemokine receptor agonists
The University of British Columbia 1061944*

Use of VIP analogues for preventing and treating brain damage in human babies
Assistance Publique – Hopitaux de Paris 1061945*

GLP-1 derivative with helix-content exceeding 25% forming partially structured micellar-like aggregates
Novo Nordisk 1061946*

Stabilised aqueous peptide solutions
Novo Nordisk 1061947*

Sustained-release preparation of physiologically active polypeptide and production thereof
Takeda Chemical Industries 1061948*

Use of cytokines and mitogens to inhibit graft versus host disease
University of Southern California 1061949*

Live vaccine for human immunodeficiency virus
Research Development Foundation 1061950*

Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
Iomai 1061951*

Analgesic combination comprising NMDA receptor antagonists and narcotic analgesics
Algos Pharmaceutical 1061953*

Poly(ethylene glycol) derivatives with proximal reactive groups
Shearwater Polymers 1061954*

Polynucleotide compsn, method of preparation, and use thereof
American Home Products 1061955*

Manganese chelates with high relaxivity in serum
Bracco; Dibra 1061956*

Radioimmuno-pharmacon for treating the HIV-1 infection.
Bergter, Wolfgang; Bergter, Ingrid-Corina 1061959*

Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
GD Searle 1062201*

Cytostatic agents
British Biotech Pharmaceuticals 1062202*

Modulators of protein tyrosine phosphatases
Novo Nordisk 1062204*

Inhibitors of phospholipase enzymes
Genetics Institute 1062205*

Amino anthracyclinone derivatives and their use in the treatment of amyloidosis
Pharmacia & Upjohn 1062206*

9-aminoacridine derivatives and process for the preparation thereof
Samjin Pharmaceuticals 1062207*

Hetaryl-substituted benzyl phenyl ethers, method for the production thereof, and their use for combating harmful fungi and animal pests
BASF 1062208*

Metabolically inert anti-inflammatory and anti-tumour antifolates
Nair, Madhavan 1062209*

1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
Vertex Pharmaceuticals 1062210*

Heterocyclyl anthracylcinone derivatives
Pharmacia & Upjohn 1062212*

Antagonists of gonadotropin releasing agents
Merck 1062215*

Inhibitors of phospholipase A2
Genetics Institute 1062216*